PRESS RELEASE published on 02/17/2023 at 15:39, 2 years 9 months ago Form 8.3 - Maitland Institutional Services Limited: Form 8.3 - OPD - Purple Bricks Group PLC
PRESS RELEASE published on 02/09/2023 at 14:15, 2 years 9 months ago Form 8.3 - Maitland Institutional Services Limited: Re Appreciate Group plc
PRESS RELEASE published on 02/09/2023 at 14:11, 2 years 9 months ago Form 8.3 - Maitland Institutional Services Limited: Re Appreciate Group plc - REPLACEMENT
PRESS RELEASE published on 02/08/2023 at 12:44, 2 years 9 months ago Form 8.3 - Maitland Institutional Services Limited: Appreciate Group Plc
PRESS RELEASE published on 01/20/2023 at 15:32, 2 years 10 months ago Form 8.3 - Maitland Institutional Services Limited: Re Mirriad Advertising plc
PRESS RELEASE published on 01/20/2023 at 15:28, 2 years 10 months ago Form 8.3 - Maitland Institutional Services Limited: Re Seraphine Group plc
Published on 12/05/2025 at 02:35, 3 hours 30 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 5 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 5 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 34 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 14 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 39 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 50 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 54 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 5 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 20 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 21 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 4 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
